Epidemiology of irritable bowel syndrome in Asia: Something old, something new, something borrowed

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 10, 2009, Pages 1601-1607

  Gwee, Kok Ann ^a   Lu, Ching Liang ^b   Ghoshal, Uday Chand ^c  

^a GLENEAGLES HOSPITAL   (Singapore)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Asia; Colonic motility; Dyspepsia; Epidemiology; Functional disorders; Irritable bowel syndrome

Indexed keywords

ASIA; BLOATING; CIVILIZATION; CLINICAL FEATURE; CONSULTATION; DEFECATION; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DYSPEPSIA; EPIGASTRIC PAIN; ETHNICITY; HEALTH EDUCATION; HUMAN; IRRITABLE COLON; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; URBAN POPULATION;

EID: 70349684934     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05984.x     Document Type: Review

References (74)

1. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999 44 : 400 406.
2. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000 47 : 804 811.
3. Chadwick VS, Chen WX, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002 122 : 1778 1783.
4. Gwee KA, Collins S M, Read NW et al. Increased rectal mucosal expression of interleukin 1B in recently acquired post-infectious irritable bowel syndrome. Gut 2003 52 : 523 526.
5. Liebregts T, Adam B, Bredack C et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007 132 : 913 920.
6. Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982 5 : 185 194.
7. Malinen E, Rinttila T, Kajander K et al. Analysis of fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 2005 100 : 373 382.
8. Kassinen A, Krogius-Kurikka L, Mäkivuokko H et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007 133 : 24 33.
9. Alun-Jones V, Wilson A, Hunter JO. The aetiological role of antibiotic prophylaxis with hysterectomy in irritable bowel syndrome. J. Obstet. Gynaecol. 1984 5 : S22 3.
10. Gwee KA, Wee S, Wong ML, Png JCD. The prevalence, symptom characteristics and impact of irritable bowel syndrome in an Asian urban community. Am. J. Gastroenterol 2004 99 : 924 931.
11. Miwa H. Prevalence of irritable bowel syndrome in Japan: internet survey using Rome III criteria. Patient Preference Adherence 2008 2 : 143 147.
12. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria, are the new Rome 2 criteria unnecessarily restrictive for research and practice? Am. J. Gastroenterol. 2000 95 : 3176 3183.
13. Hungin APS, Whorwell PJ, Tack J, Mearins F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment. Pharmacol. Ther. 2003 17 : 643 650.
14. Thompson WG. Irritable bowel syndrome: pathogenesis and management. Lancet 1993 341 : 1569 1572.
15. Bockus H. Gastroenterology, vol. 2, 2nd edn. Philadelphia, PA : WB Saunders, 1964 373.
16. Gwee KA. Irritable bowel syndrome in developing countries - disorder of civilization or colonization? Neurogastroenterol Motil. 2005 17 : 317 24.
17. Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in Mumbai. Indian J. Gastroenterol. 2001 20 : 103 106.
18. Ghoshal UC, Abraham P, Bhatt C et al. Epidemiological and clinical profile of irritable bowel syndrome in India; Report of the Indian Society of Gastroenterology Task Force. Indian J. Gastroenterol. 2008 27 : 22 8.
19. Han SH, Lee OY, Bae SC et al. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. J. Gastroenterol. Hepatol. 2006 21 : 1687 1692.
20. Kwan AC, Hu WH, Chan YK, Yeung YW, Lai TS, Yuen H. Prevalence of irritable bowel syndrome in Hong Kong. J. Gastroenterol. Hepatol. 2002 17 : 1180 1186.
21. Husain N, Chaudhry IB, Jafri F, Niaz SK, Tomenson B, Creed F. A population-based study of irritable bowel syndrome in a non-Western population. Neurogastroenterol. Motil. 2008 20 : 1022 1029.
22. Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment. Pharmacol. Ther. 2004 19 : 1217 1224.
23. Lu CL, Chen CY, Lang HC et al. Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population. Aliment. Pharmacol. Therap. 2003 18 : 1159 1169.
24. Mearin F, Badia X, Balboa A. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome 2 versus previous criteria in a general population. Scand. J. Gastroenterol. 2001 36 : 1155 1161.
25. Thompson WG, Irvine EJ, Pare P et al. Functional disorders in Canada: First population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig. Dis. Sci. 2002 47 : 225 235.
26. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population with particular reference to reflux-type symptoms. Am. J. Gastroenterol. 1998 93 : 1816 1822.
27. Tan YM, Goh KL, Muhidayah R, Ooi CL, Salem O. Prevalence of irritable bowel syndrome in young adult Malaysians: a survey among medical students. J. Gastroenterol. Hepatol. 2003 18 : 1412 1416.
28. Rajendra S, Alahuddin S. Prevalence of irritable bowel syndrome in a multi-ethnic Asian population. Aliment. Pharmacol. Ther. 2004 19 : 704 706.
29. Pan GZ, Lu S, Meiyun KE, Han SM, Guo HP, Fang XC. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by the cluster sampling. Chin. Med. J. 2000 113 : 35 9.
30. Drossman DA, Li Z, Andruzzi E et al. US household survey of functional gastrointestinal disorders. Prevalence, sociodemography and health impact. Dig. Dis. Sci. 1993 38 : 1569 1580.
31. Hu WHC, Wong WM, Lam CLK et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment. Pharmacol. Therap. 2002 16 : 2081 2088.
32. Masud MA, Hasan M, Khan AK. Irritable bowel syndrome in a rural community in Bangladesh: prevalene, symptoms pattern, and health care seeking behavior. Am. J. Gastroenterol. 2001 96 : 1547 1552.
33. Fujii Y, Nomura S. A prospective study of the psychobehavioral factors responsible for a change from non-patient irritable bowel syndrome to IBS patient status. Biopsychosoc. Med. 2008 2 : 16.
34. Kanazawa M, Endo Y, Whitehead WE, Kano M, Hongo M, Fukudo S. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig. Dis. Sci. 2004 49 : 1046 1053.
35. Lau EMC, Chan FKL, Ziea ETC et al. Epidemiology of irritable bowel syndrome in Chinese. Dig. Dis. Sci. 2002 47 : 2621 2624.
36. Kang JY, Yap I, Gwee KA. The pattern of functional and organic disorders in an Asian gastroenterological clinic. J. Gastroenterol. Hepatol. 1994 9 : 124 127.
37. Kapoor KK, Nigam P, Rastogi CK, Kumar A, Gupta AK. Clinical profile of irritable bowel syndrome. Indian J. Gastroenterol. 1985 4 : 15 16.
38. Si JM, Wang LJ, Chen SJ, Sun LM, Dai N. Irritable bowel syndrome consulters in Zhejiang province: the symptoms pattern, predominant bowel habit subgroups and quality of life. World J. Gastroenterol. 2004 10 : 1059 1064.
39. Gwee KA, Hwang JE-H, Ho K-Y, Yeoh K-G, Lum C-F, Ang P-K. In-practice predictors of response to proton pump inhibitor therapy in primary care patients with dyspepsia in an Asian population. J. Clin. Gastroenterol. 2008 42 : 134 138.
40. Lu CL, Lang HC, Chang FY et al. Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome Criteria Questionnaire Survey assisted by endoscopic exclusion among a physical check-up population. Scand. J. Gastroenterol. 2005 40 : 402 411.
41. Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhoea, constipation and symptom variation during a prospective 6-week study. Eur. J. Gastroenterol. Hepatol. 1998 10 415 422.
42. Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004 53 : 1096 1101.
43. Gwee KA, Graham JC, McKendrick MW et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996 347 : 150 153.
44. Kim YJ, Ban DJ. Prevalence of irritable bowel syndrome, influence of lifestyle factors and bowel habits in Korean students. Int. J. Nurs. Stud. 2005 42 : 247 254.
45. Jeong JJ, Choi MG, Cho YS et al. Chronic gastrointestinal symptoms and quality of life in the Korean population. World J. Gastroenterol. 2008 14 : 638 694.
46. Choo KY, Choi MG, Choi H et al. The prevalences of gastrointestinal symptoms in a rural community in Korea. Korean J. Gastrointest. Motil. 2000 6 : 31 43.
47. Ji SW, Park HJ, Lee DY, Song YK, Choi JP, Lee SI. Post-infectious irritable bowel syndrome in patients with Shigella infection. J. Gastroenterol. Hepatol. 2005 20 : 381 386.
48. Park KS, Ahn SH, Hwang JS et al. A survey about irritable bowel syndrome in South Korea. Dig. Dis. Sci. 2008 53 : 704 711.
49. Shiotani A, Miyanish T, Takahashi T. Sex differences in irritable bowel syndrome in Japanese university students. J. Gastroenterol. 2006 41 : 562 568.
50. Kumano H, Kaiya H, Yoshiuchi K, Yamanaka G, Sasaki T, Kuboki T. Comorbility of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample. Am. J. Gastroenterol. 2004 99 : 370 376.
51. Shinozaki M, Fukudo S, Hongo M et al. High Prevalence of irritable bowel syndrome in medical outpatients in Japan. J. Clin. Gastroenterol. 2008 42 : 1010 1016.
52. Sperber AD, Shvartzman P, Friger M, Fich A. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?. Eur. J. Gastroenterol. Hepatol. 2007 19 : 441 447.
53. Gwee KA. Irritable bowel syndrome and the Rome III criteria: for better or for worse? Eur. J. Gastroenterol. Hepatol. 2007 19 : 437 439.
54. Danivat D, Tankeyoon M, Sriratanaban A. Prevalence of irritable bowel syndrome in a non-western population. Br. Med. J. 1988 296 : 1710.
55. Mathur AK, Tandon BN, Prakash OM. Irritable colon syndrome a clinical and laboratory study. J. Indian Med. Assoc. 1966 46 : 651 655.
56. Pimparkar BD. Irritable colon syndrome. J. Indian Med. Assoc. 1970 54 : 95 105.
57. Bordie AK. Functional disorders of the colon. J. Indian Med. Assoc. 1972 58 : 451 456.
58. Chaudhary NA, Truelove SC. The irritable colon syndrome; a study of the clinical features, predisposing causes and prognosis in 130 cases. Q. J. Med. 1962 31 : 307 322.
59. Harvey RF, Brown AM, Mauad EC. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet 1987 1 : 963 965.
60. Talley NJ, Zinsmeister AR, Van Dyke C et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991 101 : 927 934.
61. Ghoshal UC, Gupta D, Kumar A, Misra A. Colonic transit time by radio-opaque markers to investigate constipation: Validation of a new protocol for population with rapid gut transit. Natl. Med. J. India 2007 20 : 169 173.
62. Singh N, Makharia GK, Joshi YK. Dietary survey and total dietary fiber intake in patients with irritable bowel syndrome attending a tertiary referral hospital. Indian J. Gastroenterol. 2008 27 : 66 70.
63. Tandon RK, Prasad N, Gupta NC, Tandon BN. Stool weights and transit time in Indians. J. Assoc. Physicians India. 1976 24 : 807 810.
64. Bouchoucha M, Devroede G, Arhan P et al. What is the meaning of colorectal transit time measurement? Dis. Colon Rectum 1992 35 : 773 782.
65. Chan YK, Kwan AC, Yuen H et al. Normal colon transit time in healthy Chinese adults in Hong Kong. J. Gastroenterol. Hepatol. 2004 19 : 1270 1275.
66. Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of colonic transit time. Gastroenterology 1987 92 : 40 7.
67. Gupta D, Ghoshal UC, Misra A, Misra A, Choudhuri G, Singh K. Lactose intolerance in patients with irritable bowel syndrome from northern India: a case control study. J. Gastroenterol. Hepatol. 2007 22 : 2261 2265.
68. Rana SV, Sinha SK, Sikander A et al. Study of small intestinal bacterial overgrowth in north Indian patients with irritable bowel syndrome: A case control study. Trop. Gastroenterol. 2008 29 : 23 5.
69. Baker SJ, Mathan VI. Tropical enteropathy and tropical sprue. Am. J. Clin. Nutr. 1972 25 : 1047 1055.
70. Ramakrishna BS, Venkataraman S, Mukhopadhya A. Tropical malabsorption. Postgrad. Med. J. 2006 82 : 779 787.
71. Ghoshal UC, Ghoshal U, Ayyagari A et al. Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time. J. Gastroenterol. Hepatol. 2003 18 : 887 890.
72. Anand AC, Reddy PS, Saiprasad GS, Kher SK. Does non-dysenteric intestinal amoebiasis exist? Lancet 1997 349 : 89 92.
73. Nanda R, Anand BS, Baveja U. Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects. Lancet 1984 ii : 301 303.
74. Sinha P, Ghoshal UC, Choudhuri G, Naik S, Ayyagari A, Naik SR. Does Entamoeba histolytica cause irritable bowel syndrome? Indian J. Gastroenterol. 1997 16 : 130 133.